McKesson Co. (NYSE:MCK) is Zuckerman Investment Group LLC's 4th Largest Position

Zuckerman Investment Group LLC increased its holdings in McKesson Co. (NYSE:MCK - Free Report) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,567 shares of the company's stock after acquiring an additional 1,227 shares during the period. McKesson comprises approximately 3.6% of Zuckerman Investment Group LLC's portfolio, making the stock its 4th biggest holding. Zuckerman Investment Group LLC's holdings in McKesson were worth $36,929,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of MCK. Millstone Evans Group LLC purchased a new stake in McKesson during the fourth quarter valued at about $28,000. Synergy Asset Management LLC bought a new position in shares of McKesson in the fourth quarter worth approximately $32,000. Crews Bank & Trust bought a new position in shares of McKesson in the 4th quarter worth $33,000. Atala Financial Inc purchased a new stake in McKesson during the fourth quarter valued at about $34,000. Finally, Graney & King LLC bought a new stake in McKesson in the 4th quarter worth approximately $38,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on MCK shares. Bank of America lifted their price objective on McKesson from $665.00 to $755.00 and gave the stock a "buy" rating in a report on Friday. Evercore ISI increased their target price on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Mizuho upped their price objective on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. Wells Fargo & Company lifted their price target on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a research report on Friday, March 14th. Finally, StockNews.com cut McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $668.50.

Remove Ads

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 188 shares of the business's stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares of the company's stock, valued at $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at $36,276,465.36. The trade was a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,110 shares of company stock valued at $10,855,706. 0.11% of the stock is currently owned by insiders.

McKesson Trading Down 0.3 %

McKesson stock traded down $1.76 during trading on Tuesday, reaching $692.22. The company had a trading volume of 291,880 shares, compared to its average volume of 879,808. The firm's 50-day simple moving average is $644.47 and its 200 day simple moving average is $595.30. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $728.32. The firm has a market capitalization of $86.75 billion, a price-to-earnings ratio of 31.70, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, analysts predict that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were paid a dividend of $0.71 per share. The ex-dividend date was Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.41%. McKesson's payout ratio is 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.